
11 Southeast States Offer Tips For People Living Among Alligators
As more people are move into traditional alligator habitats, 11 Southeastern states have launched the GatorWise website with pointers about how to minimize problems while living among the dangerous reptiles.
Destruction of wetland habitats where American alligators have lived is occurring throughout the Southeast due to an influx of land development due to more people living there as well as company expansions or new business locations there.
'Some states are beginning to see an uptick in nuisance alligator reports and sightings, and some of these reports are simply that an alligator exists somewhere people hadn't seen one before,' herpetologist Amanda Bryant, of the Arkansas Game and Fish Commission, stated in a May 27 state notice. 'Some states, like Florida, have done an excellent job of spreading awareness about alligator behavior and safety, and we wanted to work together to have a cohesive message throughout the American alligator's range.'
She noted the GatorWise.org website contains useful tips such as 'keeping an eye out before entering the water in alligator habitat and keeping your pets on a leash and away from the shoreline will go a long way in preventing alligator conflicts.'
In mid-May, the educational website was unveiled to promote safety between the public and wild alligators. The states behind GatorWise are Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee and Texas.
Native Range of American Alligators.
"The introduction of GatorWise is important because information about how humans should behave around alligators is similar across the southeast, but until now, each state has had to manage their own outreach sites and information,' Morgan Hart, alligator biologist, noted in a May 19 announcement by the South Carolina Department of Natural Resources. "We hope that being able to reference a central place for information will help people and alligators coexist safely.'
The state agency explained that continued 'significant human development' is expected within American alligator habitats in southeastern states. 'Alligators are a robust species that can thrive in areas where development occurs, as long as the people in these areas understand how to responsibly coexist with them,' SCDNR added.
The American alligator is a federally protected species and among North America's largest reptiles. The name alligator can be traced back to Spanish explorers who called them 'el lagarto' (the lizard).
Alligators laying on the pond's edge in Hilton Head, South Carolina.
While most people don't think of Tennessee as having alligators, the reptiles are appearing in confirmed sightings in the southwestern areas.
'What we're seeing are alligators naturally expanding their range into Tennessee from the southern border states,' says Tennessee Wildlife Resources Agency on its website. 'The TWRA has not stocked or released any alligators in Tennessee and we would like to remind everyone that possessing or releasing alligators in Tennessee is illegal and poses safety and ecological risks. Alligators expanding into Tennessee is just another species that we must learn to coexist with.'
TWRA is reminding people to refrain from feeding or harassing the alligators, which are a protected species. 'Videos have circulated recently on the internet of people poking at and interacting with alligators in Tennessee, which falls under the State of Tennessee's definition of harassing wildlife and you could be cited for any incidents of interacting with them,' TWRA says.
Alicia Wassmer, wildlife biologist with the North Carolina Wildlife Resources Commission, said in May 19 press announcement that people need to learn more about living among alligators. 'As development continues to expand into once-remote areas where alligators live, we need to become GatorWise in order to safely share the land with this species,' Wassmer said. 'Urbanization is projected to increase at exponential rates in areas where alligator habitat occurs. This continuous conversion of natural spaces, coupled with a constant influx of newcomers who may not know that alligators are here or aren't familiar with alligator behavior, have amplified the need for state wildlife resource agencies to proactively connect residents and visitors with vital information on how to coexist responsibly with the alligators that live in these communities.'
'Urbanization is projected to increase at exponential rates in areas where alligator habitat occurs,' 'This continuous conversion of natural spaces, coupled with a constant influx of newcomers who may not know that alligators are here or aren't familiar with alligator behavior, have amplified the need for state wildlife resource agencies to proactively connect residents and visitors with vital information on how to coexist responsibly with the alligators that live in these communities.'
American Alligator in Louisiana.
The GatorWise website encourages people to learn where alligators live in the different Southeastern states since each state has different alligator ranges and habitats.
Warning sign about alligators in Florida.
A South Carolina factsheet by the SCDNR offers advice for what to do when attacked by a gator. 'In the rare event that you are attacked, awareness of alligator behavior may save your life. Alligators clamp down with powerful jaws, then twist and roll. If an alligator bites your arm, it may help to grab the alligator and roll with it to reduce tearing of the arm. Strike the nose of the alligator hard and often, and try to gouge the eyes. If at all possible, do not allow the alligator to pull you into the water.'
Florida has 1.3 million alligators that live in all of the state's 67 counties. 'In recent years, Florida has experienced tremendous human population growth. Many residents seek waterfront homes, and increasingly participate in water-related activities. This can result in more frequent alligator-human interactions, and a greater potential for conflict,' says the Florida Fish and Wildlife Conservation Commission.
Another state with a sizeable population of American alligators is Louisiana, which is also home to about 1 million alligators. In Louisiana, alligators live mostly along the state's coastal marshes but also can be found in its canals, bayous, rivers and swamps. The Louisiana Wildlife and Fisheries manages American alligators as a commercial renewable natural resource by allowing wild harvesting through hunting and alligator farms where 1 million are raised. According to LDWF, Louisiana alligator farmers harvested 438,577 farm-raised alligators in 2019 valued at an estimated $86 million.
Alabama's American alligators are found throughout the state. The number has grown significantly within the past 50 years to become a public nuisance in some areas and 'now cause hundreds of complaints annually from citizens concerned about public safety,' according to the state Department of Conservation and Natural Resources. Consequently, hunting is allowed annually to curb alligator populations.
In Arkansas, larger concentrations of the gators tend to live in the state's southeastern and the southwestern corners in places with large shallow water marshes and swamps. The state's diminishing American alligators rebounded from being decimated due to hunting and lost habitat until restocking efforts from 1970s to early 1980s released over 2,840 American alligators from Louisiana. Greater numbers of the reptiles enable the state to provide regulated hunting.
Georgia is thought to have some 250,000 of the American alligators living primarily along the Fall Line (a geological boundary between the Piedmont and Coastal Plain regions) and south of it, such as around Augustus, Columbus and Macon. 'They are found in marshes, swamps, rivers, farm ponds and lakes in the wild, but also have been found in ditches, neighborhoods, drainage canals, roadways, golf course ponds and sometimes in swimming pools,' according to an Alligator Fact Sheet from the wildlife division of Georgia Department of Natural Resources.
The agency publicized the GatorWise information on its website May 29. 'As the weather warms up and people are spending more time outdoors, it's a great time to remind everyone that it is normal to see alligators moving around and basking in rivers, ponds and lakes in the southern part of the state,' said Kara Nitschke, state wildlife resources divison alligator biologist. 'Alligators are native to Georgia and are critical to the health and balance of our ecosystems, so being GatorWise means we know how to modify our behavior to minimize any potential conflict.'
Mississippi has between 32,000 and 38,000 alligators. The area with the most (nearly 25%) is Jackson County, followed by Hancock County and about 408,000 acres of alligator habitat in. Both counties are at the tip of the Gulf coastline. However, people living in Rankin County are more likely to come across a gator since there. The state determines its alligator populations by counting at night eyeshine counts using lights to document how many alligator eyeballs they find, which appear as orange under the illumination.
'Night-light surveys over the last three years indicate that Rankin County has the highest alligator densities in the state, averaging 7.35 alligators per mile along survey routes, versus an average of 1.76 alligators per mile for the rest of the state. Most of the Rankin County alligator population is located in and around Ross Barnett Reservoir and in the Pearl River to Ratliff Ferry,' says the Mississippi Department of Wildlife, Fisheries and Parks.
North Carolina's gators tend to live north of Albemarle Sound, south along the eastern coast and as far west as in Robeson County. The two southernmost coastal counties of New Hanover and Brunswick are where most of the alligator nuisance reports are coming from.
The state passed a law nearly 20 years ago to deter people from feeding alligators. 'Alligators are usually shy and secretive in nature. If fed, they can lose their natural fear of humans and learn to associate people with an easy meal,' stated the North Carolina Alligator Management Plan issued in 2017 by the NCWRC. 'The perception many individuals have that every alligator is a dangerous nuisance, misconceptions about alligator behavior and biology, public unawareness that alligators exist in North Carolina, and the transient nature of human populations in some areas (e.g., military bases, vacation destinations, recreational areas) all contribute to the need for a strong and continual education and outreach program to keep the public informed.'
South Carolina's alligators live in coastal marsh areas but can be found in retention pounds rivers, streams and lakes. Each year there are from 300 to 350 alligators removed and euthanized due to public safety concerns posed to people and their pets. The SCDNR does not relocate alligators because they return to their habitats. 'Alligators have a strong homing instinct. Adult alligators will attempt to return home even after they've been moved many miles, crossing anything in their way to get back, including backyards and highways,' SCDNR says.
American alligators in Oklahoma live primarily in isolated areas and marshlands in the state's southeastern corner. The counties that are the home to most alligators in Oklahoma are Choctaw and McCurtain.
American Alligator locations in Texas.
In Texas, American alligators live in a wide swath from the tip of the state in Brownsville at the Gulf up to the entire eastern side. 'With the human population in Texas continuing to expand, increased contact between people and alligators can be expected,' noted a Texas Parks & Wildlife Department factsheet. 'Alligators naturally shy away from humans. However, problems do arise when people feed alligators because the alligator loses its fear of humans and begins to associate people with food. This produces a potentially dangerous situation. An alligator that has been frequently hand-fed will often lunge at an outstretched hand. This action is often interpreted as an 'alligator attack' when in reality the alligator has been conditioned to respond to an outstretched hand expecting to be fed. For this reason, it is wrong to feed any wild alligator.'
Alligator activity.
Alligators are thought to have a key role in balancing wetland ecosystems. They can live as long as 50 years in the wild and aren't generally safe from being killed by predators (except people) after they grow more than four feet long. Raccoons, bears, otters and hogs are known to eat alligator eggs in nests. Young gators can become the prey of otters, fish, raccoon, wading birds and even larger alligators.
American alligators mostly stay in areas where they were hatched from eggs between two and three years before they move to find their own ranges. Their body size can be from 6 to 14 feet long. Male alligators can weigh 1,000 pounds. Their front feet have 5 toes, while the back feet have 4 webbed toes. Other unusual characteristics is they have two sets of eyelids (a vertical one human like and a horizontal transparent membrane one) and teeth that grown back. A single alligators can grow 3,000 teeth in its lifetime. Juvenile alligators can eat amphibians, insects, amphibians and small fish, while adults consume snakes, birds, turtles, rough fish, small mammals and other opportunistic prey.
'Both males and females vocalize. The male calls with a loud, throaty bellow and may hiss and inflate to impress a mate. Females bellow and grunt, too, but less loudly. Young alligators call with a high-pitched chirp,' notes the NCWRC.
A recently published study by Christopher M. Murray, Tyler S. Coleman, Wray Gabel and Ken Krauss looked at the role American alligators play in wetland ecosystems as helping to regulate carbon stored in soil, which has decomposed plants. 'Results indicate that American alligator presence is positively correlated with soil carbon stock across habitats within their native distribution,' noted a U.S. Geological Service article on the study,'American Alligators (Alligator Nississippiensis) as Wetland Ecosystem Carbon Stock Regulators.'
Researchers are examining links between climate change and mitigation strategies such as the use of natural carbon stored in soils. This role that alligators are thought to play in the environment is among their place as an apex predator regulating ecosystem populations in wetlands.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fast Company
16 minutes ago
- Fast Company
Wegovy and Zepbound patients are resorting to these cost-saving measures to stay on the weight-loss drugs
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but as more U.S. insurers restrict coverage people are trimming costs by stretching doses or forgoing expenditures like vacations to pay for the medication out of pocket. A half dozen doctors who spoke with Reuters said insurance coverage has tightened in 2025 as many employers drop it for the expensive GLP-1 drugs. While patients on these medications are counseled on proper diet and exercise, clinical trials show that people who stop taking these drugs are apt to regain weight. Novo Nordisk's Wegovy and Eli Lilly's Zepbound are weekly injections with U.S. insurer list prices of more than $1,000 a month. For customers willing to pay cash, both drugmakers will ship directly for $499 a month if refills are purchased at fixed intervals. 'A significant number of my patients now pay cash,' said Dr. Nidhi Kansal, an obesity specialist at Northwestern Medicine in Chicago. 'People find a way to scrounge up $6,000 a year, which sucks, because that's a vacation or two.' Subscribe to the Daily newsletter. Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters More than a billion people worldwide are obese, according to the U.N. World Health Organization, which has said the GLP-1 drugs could help end the obesity pandemic. 'A KIND OF PURGATORY' A tech industry job change for Yelena Kibasova, a 40-year-old who lives in the Minneapolis area, meant loss of coverage for her Zepbound prescription that helped her achieve and maintain a 150-pound (68-kg) weight loss. GLP-1 patient Yelena Kibasova, 40, poses in this undated handout picture. [Photo: @morethanmyweight/Handout via Reuters] 'My new company does not cover GLP-1s, so now I am in a kind of purgatory,' Kibasova said. 'I stopped doing my nails. I stopped doing my hair. Those things are not as important as me staying at a healthy weight.' The doctors interviewed by Reuters said patients once leery about long-term obesity treatment are now more comfortable staying on a drug. The doctors said that conversations about temporary use happen only when a patient is trying to lose a certain amount of weight for issues such as fertility treatment or an organ transplant. These obesity specialists said they are hopeful that competition will help bring down prices as new weight-loss options emerge, including new oral drugs that may be available next year. Lilly last week announced trial results for its easier-to-manufacture pill, which was shown to cut patient weight by 12.4%, a few percentage points less than injected drugs. The company hopes to launch it in August 2026. Kenneth Custer, Lilly's head of cardiometabolic health, told Reuters the pill is being tested in several settings, including as a maintenance therapy. Custer declined to comment on how it might be priced. MEDICATION FOR MAINTENANCE Dr. Anne Peters, an endocrinologist at Keck Medicine USC in Los Angeles, said it is important that patients who reach their weight-loss goal not stop a prescription 'cold turkey,' so the dose can be tapered down over several months. Peters said about a third of her patients are able to reduce their dose and maintain weight loss, while the rest need to stay on the medication. An analysis of U.S. pharmacy insurance claims found that nearly two-thirds of patients who started on Wegovy or Zepbound in 2024 were still on the medications a year later. advertisement Peters said she uses 'every technique in the book' to secure insurance coverage for patients, but noted that a growing number of plans no longer pay for the treatments, and patients have to pay out-of-pocket. U.S. pharmacies supply self-injection pens pre-loaded with doses of Wegovy or Zepbound. Lilly's direct-to-consumer service also offers vials. 'Some patients can stretch out the vials longer. Get 15 mg, and then give a 10 mg dose for instance,' Dr. Peters said, noting that the drug's instructions advise that such an approach should not be taken. Doses of 5 mg, 10 mg and 15 mg are recommended for weight-loss maintenance. Patients also are turning to lower-cost compounded versions of the GLP-1 drugs, or are even mixing them at home with raw ingredients, both of which Peters and other doctors advise against due to safety concerns. Dr. Angela Fitch, former president of the Centennial, Colorado-based Obesity Medicine Association and chief medical officer at online primary care provider Knownwell, said nobody wants to be on a medication, but patients who respond to a GLP-1 drug 'really don't want to go off of it when they recognize that it has such a value to them.' Both Wegovy and Zepbound were first launched, under the brand names Ozempic and Mounjaro, as diabetes treatments. The class has been linked to a range of benefits, including improved heart health and less sleep apnea. Fitch said the most common reason for her patients to stop taking a GLP-1 drug is loss of insurance coverage. She said her experience is that about 10% of patients are able to reach a target weight and maintain it without further treatment. 'We are in a dip where people are dropping coverage,' Fitch said, adding that the direct-to-consumer options are an 'upper-ish middle-class thing.' —Deena Beasley, Reuters


Medscape
16 minutes ago
- Medscape
Optimizing Therapies for HR+ Early-Stage Breast Cancer
Hormone receptor-positive (HR+) early-stage breast cancer is one of the most common types of breast cancer, characterized by tumor cells that have receptors for estrogen or progesterone hormones. Although significant progress has been made in screening, treatment, and surgery, the risk of recurrence still remains. To explore therapies for managing HR+ early-stage breast cancer, Medscape spoke with Hope S. Rugo, MD, FASCO, division chief of breast medical oncology and a professor of medical oncology and therapeutics research at City of Hope Comprehensive Cancer Center, Duarte, California, and professor emeritus at the University of California San Francisco. Read on for her insights. What role does risk stratification play in determining therapy for HR+ early-stage breast cancer? Hope S. Rugo, MD, FASCO This is a critical area. It is a key aspect of determining appropriate treatment and extent of treatment, and we are still learning more about how to appropriately stratify based on clinicopathologic and genomic characteristics. Gene expression tests are used widely to understand prognosis and benefit from chemotherapy, but there are ongoing issues in HR+ disease including disease heterogeneity and how to optimally treat very young women with HR+ disease. We use clinicopathologic data in combination with gene expression tests to stratify risk, but this approach doesn't always provide us with the necessary information for determining the optimal adjuvant or neoadjuvant treatment. The adjuvant CDK4/6 inhibitor trials will be helpful, as they will allow for longer follow-up of patients with high- and intermediate-risk disease. Additionally, newer predictors, such as gene expression signatures that may estimate the benefit from immunotherapy, are also being evaluated. What factors influence your choice between endocrine therapy and chemotherapy for HR+ early-stage breast cancer? Multiple factors have an influence on the choice of therapy, including the extent of disease and tumor biology. We have also learned that the intensity or extent of estrogen positivity plays a role in endocrine sensitivity. In terms of tumor biology, understanding tumor proliferation and chemotherapy sensitivity is critical. We are currently using gene expression tests, but it is clear that these are insufficient, even within the context of age and tumor burden. Additional markers that help to identify up-front or emerging resistance to endocrine therapy are critical. Data from the CDK4/6 inhibitor adjuvant trials has further complicated this question — as now the issue is where optimal outcome can be achieved in less chemotherapy-responsive, higher-risk disease with the addition of abemaciclib or ribociclib. Considering recent research, is extended endocrine therapy actually beneficial? I believe it is, but careful consideration needs to be given to the decision to extend therapy. Disease burden is of course our first consideration, but sensitivity to endocrine therapy, development of resistance, and response to chemotherapy in appropriate cases need to be taken into consideration. Interestingly, several analyses have suggested that patients with low proliferative and genomic risk, but a higher disease burden, might be most likely to benefit from extended duration endocrine therapy due to the long natural history of this disease. We are now exploring the use of switching the type of endocrine therapy in the high-risk adjuvant setting and the use of circulating tumor DNA (ctDNA) to optimize therapy. What role do CDK4/6 inhibitors play in the adjuvant setting for HR+ early-stage disease? Both abemaciclib and ribociclib have reduced the risk of recurrence and the risk of distant recurrence in patients with intermediate or high-risk early-stage breast cancer. The duration of therapy varies, and eligibility criteria overlap; however, the recent NATALEE trial included a diverse population, including an intermediate-risk group (stage II, node-negative with additional risk factors) to evaluate the role of the CDK4/6 inhibitors among such populations. The striking aspect of this trial was the carry-over effect, shown most clearly in the monarchE study with 5-year follow-up. Even 3 years after completing treatment with abemaciclib, the data showed an increasing impact on disease-free survival and distant disease-free survival. Although there has been no overall survival impact yet, fewer patients with abemaciclib in monarchE are living with metastatic disease. What are the most critical research gaps or upcoming trials that could reshape how we manage HR+ early-stage breast cancer in the upcoming years? A few main things to address are improving risk stratification, how to use ctDNA to improve outcome, and understanding if use of oral selective estrogen receptor degrader (SERDs) in sequence improve outcome and their optimal therapy duration. So far, studies using ctDNA to assess risk and guide therapy changes have been challenging due to the low number of positive ctDNA results. Moreover, ctDNA detection has sometimes coincided with metastatic disease already visible on scans in case of several aggressive cancers. We still don't know the optimal treatment approach when molecular evidence of disease is found, which is making studies focus on adding targeted therapy or changing endocrine therapy. Several trials are evaluating oral SERDs in the early stage setting for the treatment of high-risk disease. While these trials will also collect ctDNA, patient eligibility is not based on these tests. One very important area that requires additional research is understanding early-stage breast cancer in young women, where tumors seem to behave poorly — particularly in women under the age of 40 — even when patients are treated with optimal therapy. Understanding optimal therapy is a key research focus, and further investigation of biological drivers in both ductal and lobular cancers is warranted. The OFFSET trial aims to determine the value of adjuvant chemotherapy vs ovarian function suppression in conjunction with standard endocrine therapy and CDK4/6 inhibitors as indicated. However, this study is challenging to enroll in. Hope S. Rugo, MD, FASCO, has disclosed the following relevant financial relationships: Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Chugai; Puma; Sanofi; Napo; Mylan Received research grant from: AstraZeneca; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche AG/Genentech, Inc.; Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Stemline Therapeutics; OBI Pharma; Ambrx


Fox News
17 minutes ago
- Fox News
Cowboys' Jerry Jones reveals scary skin cancer battle
Dallas Cowboys team owner Jerry Jones revealed he overcame an off-the-field battle as he holds out hope that the organization he helped make one of the most valuable in sports reaches the Super Bowl once more. Jones revealed in an interview with the Dallas Morning News that he was diagnosed with stage 4 melanoma skin cancer in June 2010 and started his treatment soon after. The report noted that Jones slightly touched on undergoing cancer treatments a "dozen years ago" during one of the episodes of the Netflix docuseries "America's Team: The Gambler and His Cowboys." "I was saved by a fabulous treatment and great doctors and a real miracle (drug) called PD-1 (therapy)," he told the Morning News. "I went into trials for that PD-1 and it has been one of the great medicines. "I now have no tumors." Jones said he's had four surgeries over the last 10 years – two on his lungs and two to deal with his lymph nodes. Melanoma is a less common form of skin cancer that is more dangerous than other varieties because it's much more likely to spread to other parts of the body if not found and treated early, according to the American Cancer Society. The Melanoma Research Alliance said stage 4 means the cancer "metastasized (spread) to other places throughout the body, such as the brain, lungs, liver, or gastrointestinal (GI) tract." "The 5-year survival rate as of 2018 for distant metastatic (Stage IV) melanoma is 22.5%," the research organization stated on its website. Jones, 82, is set to embark on another NFL season as the head of the Cowboys. Sportico revealed its NFL valuations on Wednesday with the Cowboys leading the league at $12.8 billion.